Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11180782-B2

Patent

Publication Date

2021-11-23

Expiration Date


Abstract

The present disclosure relates to methods for producing oxygenated terpenoids, and preparation of compositions and formulations thereof. Polynucleotides, derivative enzymes, and host cells for use in such methods are also provided.

Core Innovation

The invention describes a method of sustainable production of oxygenated sesquiterpenes by contacting sesquiterpene substrates, including valencene, with Stevia rebaudiana Kaurene Oxidase (SrKO) (CYP701A5) or engineered SrKO derivatives having valencene oxidizing activity. The oxidizing contact is performed in an in vitro or in vivo system to produce an oxygenated product.

The disclosure emphasizes that SrKO has an unexpected sesquiterpene oxidation profile, producing both α-nootkatol and β-nootkatol and further oxidation to nootkatone, while also producing other oxygenated terpene products. The oxidation profile is contrasted with other P450s that primarily yield only one stereoisomer and little ketone.

Engineered SrKO derivatives and their expression are described in microbial hosts, including N-terminal membrane-anchor engineering for expression in E. coli. Cofactor support is described through cytochrome P450 reductase (CPR) partners, including optional fused SrKO/CPR constructs, and downstream pathway setup is described for isopentenyl pyrophosphate (IPP) generation and terpenoid synthesis toward valencene and related intermediates.

The disclosure further describes conversion of nootkatol toward nootkatone and recovery and use of oxygenated products by recovery/blending into flavor, fragrance, cosmetic, and cleaning products, including formulation compositions comprising nootkatone, α-nootkatol, and β-nootkatol.

Claims Coverage

Not explicitly described in patent.

Not explicitly described in patent.

Stated Advantages

Sustainable production of oxygenated sesquiterpenes including nootkatone, α-nootkatol, and β-nootkatol.

Production of both α-nootkatol and β-nootkatol and further oxidation to nootkatone, and additional oxygenated terpene products.

Unexpected sesquiterpene oxidation profile compared to other P450s that primarily yield only one stereoisomer and little ketone.

In vitro or in vivo production of an oxygenated product comprising nootkatone, α-nootkatol, and β-nootkatol.

Production of formulations comprising nootkatone, α-nootkatol, and β-nootkatol.

Documented Applications

Flavor, fragrance, cosmetic, and cleaning products using recovery/blending of oxygenated products and specified formulation compositions comprising nootkatone, α-nootkatol, and β-nootkatol.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.